FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021150754> ?p ?o ?g. }

• W2021150754 endingPage "2297" @default.
• W2021150754 startingPage "2286" @default.
• W2021150754 abstract "A series of N-(arylalkyl)indol-3-ylglyoxylylamides (4−8) was synthesized as ligands of the benzodiazepine receptor (BzR) and tested for their ability to displace [3H]flumazenil from bovine brain membranes. The new compounds, bearing a branched (4) or a geometrically constrained benzyl/phenylethyl amide side chain (5−8), represent the continuation of our research on N-benzylindol-3-ylglyoxylylamides 1 (Da Settimo et al., 1996), N‘-phenylindol-3-ylglyoxylohydrazides 2 (Da Settimo et al., 1998), and N-(indol-3-ylglyoxylyl)alanine derivatives 3 (Primofiore et al., 1989). A few indoles belonging to the previously investigated benzylamides 1 and phenylhydrazides 2 were synthesized and tested to enrich the SARs in these two series. The affinities and the GABA ratios of selected compounds for clonal mammalian α1β2γ2, α3β2γ2, and α5β3γ2 BzR subtypes were also determined. It was hypothesized that the reduced flexibility of indoles 4−8 would both facilitate the mapping of the BzR binding cleft and increase the chances of conferring selectivity for the considered receptor subtypes. In the series of indoles 4, the introduction of a methyl group on the benzylic carbon with the R configuration improved affinity of the 5-substituted (5-Cl and 5-NO2) derivatives, whereas it was detrimental for their 5-unsubtituted (5-H) counterparts. All S enantiomers were less potent than the R ones. Replacement of the methyl with hydrophilic substituents on the benzylic carbon lowered affinity. The isoindolinylamide side chain was tolerated if the 5-position was unsubstituted (Ki of 5a = 123 nM), otherwise affinity was abolished (5b, c). All the 2-indanylamides 6 and (S)-1-indanylamides 8 were devoid of any appreciable affinity. The 5-Cl and 5-NO2 (R)-1-indanylamides 7b (Ki 80 nM) and 7c (Ki 28 nM) were the most potent among the indoles 5−8 geometrically constrained about the side chain. The 5-H (R)-1-indanylamide 7a displayed a lower affinity (Ki 675 nM). The SARs developed from the new compounds, together with those collected from our previous studies, confirmed the hypothesis of different binding modes for 5-substituted and 5-unsubstituted indoles, suggesting that the shape of the lipophilic pocket L1 (notation in accordance with Cook's BzR topological model) is asymmetric and highlighted the stereoelectronic and conformational properties of the amide side chain required for high potency. Several of the new indoles showed selectivity for the α1β2γ2 subtype compared with the α3β2γ2 and α5β3γ2 subtypes (e.g.: 4t and 7c bind to these three BzR isoforms with Ki values of 14 nM, 283 nM, 239 nM, and 9 nM, 1960 nM, 95 nM, respectively). The GABA ratios close to unity exhibited by all the tested compounds on each BzR subtype were predictive of an efficacy profile typical of antagonists." @default.
• W2021150754 created "2016-06-24" @default.
• W2021150754 creator A5002153460 @default.
• W2021150754 creator A5010550259 @default.
• W2021150754 creator A5026476213 @default.
• W2021150754 creator A5033152058 @default.
• W2021150754 creator A5040940946 @default.
• W2021150754 creator A5051863495 @default.
• W2021150754 creator A5067808979 @default.
• W2021150754 creator A5074047610 @default.
• W2021150754 creator A5076211653 @default.
• W2021150754 creator A5083327774 @default.
• W2021150754 creator A5089468313 @default.
• W2021150754 date "2001-06-12" @default.
• W2021150754 modified "2023-09-25" @default.
• W2021150754 title "Novel <i>N</i>-(Arylalkyl)indol-3-ylglyoxylylamides Targeted as Ligands of the Benzodiazepine Receptor: Synthesis, Biological Evaluation, and Molecular Modeling Analysis of the Structure−Activity Relationships" @default.
• W2021150754 cites W1532848864 @default.
• W2021150754 cites W1775749144 @default.
• W2021150754 cites W1979541512 @default.
• W2021150754 cites W1980661175 @default.
• W2021150754 cites W1981301927 @default.
• W2021150754 cites W1990822015 @default.
• W2021150754 cites W2008517160 @default.
• W2021150754 cites W2017206888 @default.
• W2021150754 cites W2021712537 @default.
• W2021150754 cites W2028936835 @default.
• W2021150754 cites W2035700792 @default.
• W2021150754 cites W2039267782 @default.
• W2021150754 cites W2057046039 @default.
• W2021150754 cites W2063388752 @default.
• W2021150754 cites W2084906880 @default.
• W2021150754 cites W2094899308 @default.
• W2021150754 cites W2095575967 @default.
• W2021150754 cites W2161239029 @default.
• W2021150754 cites W2323522150 @default.
• W2021150754 cites W2950601179 @default.
• W2021150754 cites W2951425679 @default.
• W2021150754 doi "https://doi.org/10.1021/jm010827j" @default.
• W2021150754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11428922" @default.
• W2021150754 hasPublicationYear "2001" @default.
• W2021150754 type Work @default.
• W2021150754 sameAs 2021150754 @default.
• W2021150754 citedByCount "29" @default.
• W2021150754 countsByYear W20211507542013 @default.
• W2021150754 countsByYear W20211507542015 @default.
• W2021150754 countsByYear W20211507542017 @default.
• W2021150754 countsByYear W20211507542018 @default.
• W2021150754 countsByYear W20211507542019 @default.
• W2021150754 countsByYear W20211507542020 @default.
• W2021150754 countsByYear W20211507542021 @default.
• W2021150754 countsByYear W20211507542022 @default.
• W2021150754 countsByYear W20211507542023 @default.
• W2021150754 crossrefType "journal-article" @default.
• W2021150754 hasAuthorship W2021150754A5002153460 @default.
• W2021150754 hasAuthorship W2021150754A5010550259 @default.
• W2021150754 hasAuthorship W2021150754A5026476213 @default.
• W2021150754 hasAuthorship W2021150754A5033152058 @default.
• W2021150754 hasAuthorship W2021150754A5040940946 @default.
• W2021150754 hasAuthorship W2021150754A5051863495 @default.
• W2021150754 hasAuthorship W2021150754A5067808979 @default.
• W2021150754 hasAuthorship W2021150754A5074047610 @default.
• W2021150754 hasAuthorship W2021150754A5076211653 @default.
• W2021150754 hasAuthorship W2021150754A5083327774 @default.
• W2021150754 hasAuthorship W2021150754A5089468313 @default.
• W2021150754 hasConcept C114373084 @default.
• W2021150754 hasConcept C118792377 @default.
• W2021150754 hasConcept C161790260 @default.
• W2021150754 hasConcept C170493617 @default.
• W2021150754 hasConcept C178790620 @default.
• W2021150754 hasConcept C185592680 @default.
• W2021150754 hasConcept C193042331 @default.
• W2021150754 hasConcept C202751555 @default.
• W2021150754 hasConcept C204921945 @default.
• W2021150754 hasConcept C24961977 @default.
• W2021150754 hasConcept C2778439535 @default.
• W2021150754 hasConcept C2780283098 @default.
• W2021150754 hasConcept C486523 @default.
• W2021150754 hasConcept C521977710 @default.
• W2021150754 hasConcept C55493867 @default.
• W2021150754 hasConcept C71240020 @default.
• W2021150754 hasConceptScore W2021150754C114373084 @default.
• W2021150754 hasConceptScore W2021150754C118792377 @default.
• W2021150754 hasConceptScore W2021150754C161790260 @default.
• W2021150754 hasConceptScore W2021150754C170493617 @default.
• W2021150754 hasConceptScore W2021150754C178790620 @default.
• W2021150754 hasConceptScore W2021150754C185592680 @default.
• W2021150754 hasConceptScore W2021150754C193042331 @default.
• W2021150754 hasConceptScore W2021150754C202751555 @default.
• W2021150754 hasConceptScore W2021150754C204921945 @default.
• W2021150754 hasConceptScore W2021150754C24961977 @default.
• W2021150754 hasConceptScore W2021150754C2778439535 @default.
• W2021150754 hasConceptScore W2021150754C2780283098 @default.
• W2021150754 hasConceptScore W2021150754C486523 @default.
• W2021150754 hasConceptScore W2021150754C521977710 @default.
• W2021150754 hasConceptScore W2021150754C55493867 @default.
• W2021150754 hasConceptScore W2021150754C71240020 @default.
• W2021150754 hasIssue "14" @default.
• W2021150754 hasLocation W20211507541 @default.

• next